Sponsors (6)
The bill provides modest, targeted annual funding and a streamlined advisory phrasing to support federal and state/local vector-borne disease work, but the amounts are smaller than prior authorizations, remain subject to appropriation, and the advisory change may reduce transparency and formal stakeholder input.
State and local health departments receive $9 million per year (FY2026–2030) to expand surveillance, prevention, and response for vector-borne diseases, strengthening local public-health capacity.
A federal vector-borne disease program is authorized $8 million per year (FY2026–2030) to support national surveillance, prevention, and response activities, improving coordination and technical support.
Clarifying the advisory reference to 'appropriate individuals' may streamline who HHS consults and speed some decision-making or advisory processes.
Authorized amounts do not guarantee funding—Congress must appropriate these dollars, so programs could still face shortfalls depending on future budgets.
The annual authorized funding levels are lower than the prior authorization (about $10 million), potentially reducing resources available for state and local vector-borne disease efforts.
Replacing a named advisory body with consultation by 'appropriate individuals' could reduce formal stakeholder input and transparency about who advises HHS.
Based on analysis of 2 sections of legislative text.
Replaces a named working‑group reference with "appropriate individuals" and authorizes $8M and $9M annually for two vector‑borne disease programs for FY2026–2030.
Official title: Reauthorize the Kay Hagan Tick Act, and for other purposes.
Introduced July 15, 2025 by Susan Margaret Collins · Last progress July 15, 2025
Amends two provisions of the Public Health Service Act to update language describing who may be consulted for tick‑borne disease work and to reauthorize/adjust funding for two vector‑borne disease programs. It replaces a specific named reference to the Tick‑Borne Disease Working Group with a broader phrase allowing consultation with “appropriate individuals,” and sets new statutory authorizations of $8,000,000 per year and $9,000,000 per year for two programs to support vector‑borne disease activities for FY2026–2030.